Molisch's test

KSL | Pulse Scientific Named National Distributor in Canada for First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

Retrieved on: 
Tuesday, November 29, 2022
Infectious Diseases, Health, COVID-19, Medical Supplies, COVID-19, Hospital Insurance and Diagnostic Services Act, Genetics, KSL, Virology, Influenza, Molisch's test, Microbiology, AA, Hand, Genomics, Multimedia, Health Canada, Safety, EUA, Patient, Test, CLIA, STI, PCR, Power-on self-test, Pulse, COVID, National Association Medical Staff Services, Health, Research, NAAT, Interim order, ISO, Urinary tract infection, Lucira, Clinical trial, CAP, FDA, Pharmaceutical industry, Medical device, EU

The Lucira COVID-19 & Flu Test is a 99% accurate rapid molecular test that delivers results in 30 minutes or less from one shallow nasal swab.

Key Points: 
  • The Lucira COVID-19 & Flu Test is a 99% accurate rapid molecular test that delivers results in 30 minutes or less from one shallow nasal swab.
  • View the full release here: https://www.businesswire.com/news/home/20221129005267/en/
    KSL | Pulse Scientific named national distributor in Canada for first-of-its-kind Covid-19 & Flu at-home molecular test.
  • Developed by Lucira Health, this 99% accurate test approved by Health Canada is now available for the COVID/Flu season.
  • Because Australia had an alarming spike in COVID and flu cases and we could see a substantial increase in North America.

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

Retrieved on: 
Thursday, May 12, 2022
Severe acute respiratory syndrome coronavirus 2, CEO, Private Securities Litigation Reform Act, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, CE marking, Electric Bond and Share Company v. Securities and Exchange Commission, EUA, Urinary tract infection, Jabil, Risk, STI, COVID-19, FDA, NAAT, Time, Clinical trial, Molisch's test, AA, Influenza, Forward-looking statement, PCR, Maintenance, Therapy, Sexually transmitted infection, Security (finance), Hand, Annual report, GLOBE, Pharmaceutical industry, Lucira

The Lucira COVID-19 & Flu test uses the same platform and palm-sized device design and independently tests for COVID-19, Flu A, and Flu B from a single nasal swab.

Key Points: 
  • The Lucira COVID-19 & Flu test uses the same platform and palm-sized device design and independently tests for COVID-19, Flu A, and Flu B from a single nasal swab.
  • Clinical trial results with the Lucira COVID-19 & Flu test were positive, demonstrating comparable sensitivity and specificity to leading lab-based PCR assays.
  • The Lucira COVID-19 & Flu test is a NAAT test utilizing the same platform and device design as Lucira's commercialized EUA authorized COVID-19 tests to provide independent diagnoses for COVID-19, Flu A, and Flu B.
  • Each Lucira test contains everything needed to run a single COVID-19 test: the test device, two AA batteries, sample vial, swab, and simple instructions.

Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society Workers

Retrieved on: 
Thursday, March 31, 2022
Thai Red Cross Society, Nukuʻalofa, Multimedia, PCR, NAAT, Sutter Health, Aetna Health Inc. v. Davila, Tonga Red Cross Society, View, Cleveland Clinic, Hunga, Atmosphere of Earth, Safety, Air Canada, COVID-19, Lucira, List of Red Cross and Red Crescent Societies, AA, Salesforce, Island, Infection, Ministry, Molisch's test, Volunteering, List of health departments and ministries, Pharmaceutical industry, Animal, Vaccine, Amazon, Health

EMERYVILLE, Calif., March 31, 2022 /PRNewswire/ -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, donated 2,000 Lucira™ Check-It COVID-19 tests, a rapid at-home test with PCR-quality accuracy, for Tonga humanitarian efforts after the eruption of the Hunga Tonga-Hunga Ha'apai volcano in January 2022. The Tonga Red Cross Society was immediately on the scene of the disaster providing relief to local communities, as the tsunami reportedly caused waves as high as 49 feet on the low elevation islands.

Key Points: 
  • Lucira coordinated with the Tongan government's Ministry of Health and Air New Zealand to donate and deliver Lucira Check-It COVID-19 test kits to protect the health and safety of the staff and volunteers of the Tonga Red Cross Society, who supplied immediate support to affected communities.
  • Each Lucira Check-It test contains everything needed to run a single COVID-19 test.
  • Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries.
  • Lucira designed its test kits to provide accurate, reliable, and on-the-spot molecular test results anywhere and at any time.

First-of-its-kind Cue Health Partnership with Air Canada Provides U.S.-based Customers with Special Access to the Most Accurate COVID-19 Self-Test

Retrieved on: 
Tuesday, December 21, 2021
PSAR, Federal Food, Drug, and Cosmetic Act, Travel, National Basketball Association, EUA, CE, School, Entrepreneurship, NBA, FDA, NAAT, Union, Hospital, Health, Trial of the century, Mayo Clinic, Virus, Diagnosis, Emergency Use Authorization, Form, OTC, SAN, Central Drugs Standard Control Organisation, Power-on self-test, MLB, COVID-19, Nursing, Nasdaq, Air Canada Rouge, Partnership, Severe acute respiratory syndrome coronavirus 2, Molisch's test, Hand, Major League Baseball, DTC, National, Prison, Risk, Use, SEC, Interim order, Senior, Multimedia, View, Health Canada, Omicron, Health Sciences Authority, Air Canada, Pharmaceutical industry, Cassette tape, Google, Cue

Under this partnership, each Cue test comes with access to a video proctoring session within the Cue Health App.

Key Points: 
  • Under this partnership, each Cue test comes with access to a video proctoring session within the Cue Health App.
  • "Together with Air Canada, we can now equip U.S. passengers with access to their health information in real-time, providing people with much-needed peace of mind before and after their flights."
  • "Together with Cue Health, we're excited to extend our industry-leading range of testing options that make travelling easier and more predictable.
  • Cue has received Interim Order authorization from Health Canada to sell and distribute its COVID-19 test for both point-of-care and self-testing.